Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-09

Clinical Trial Update: Role of High-Throughput Whole Genome Sequencing for the Diagnosis and Care of Atypical Diabetes [NA]

View source ↗

Summary

This clinical trial investigates high-throughput whole genome sequencing to improve diagnosis and management of atypical diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Diabetes Mellitus | NA | Status: RECRUITING